mynth
← DATABASE
05/2018

PARAGON MEDICAL acquired by NN

UNITED STATES Life Sciences / Medical Devices EV $300–700M

Context

The integration of Paragon Medical into the NN, Inc. life sciences portfolio represents a definitive shift in the group's overarching corporate strategy. By absorbing Paragon Medical, NN, Inc. significantly enhances its technical proficiencies and diversifies its finished device offerings, moving beyond traditional industrial components into highly regulated healthcare markets. The strategic rationale for the transaction centers on the fusion of Paragon Medical’s niche leadership in orthopedic instrumentation with NN, Inc.’s global manufacturing scale and materials science depth. This operation allows NN, Inc. to build a more balanced business model, mitigating exposure to volatile industrial cycles by capturing non-discretionary demand in the surgical hardware space. The partnership acts as a catalyst for geographic and technical expansion, providing the strategic resources required to scale Paragon Medical's specialized capabilities across an international platform. Ultimately, the merger consolidates a high-performance life sciences division, positioning the organization as a primary enabler of medical device innovation and precision manufacturing on a global scale.

PARAGON MEDICAL, which reported an EBITDA margin of [members only] in 2017, is valued in this transaction at an EV/EBITDA multiple of 15x–25x, representing a premium to the average currently observed in the Healthcare & Pharma sector (14.3x).

-> Deep-dive in Healthcare & Pharma market trends

Target

Paragon Medical functions as a premier technology-driven organization specializing in the design, engineering, and manufacturing of critical medical components and surgical instruments. The entity’s business model is built on an industrialized framework as a contract development and manufacturing organization (CDMO), providing technical operational depth to global medical device leaders. Its value proposition is anchored in high-precision micro-machining and specialized metallurgy for orthopedic implants, robotic surgical tools, and drug delivery systems. Strategically, the firm focuses on being a mission-critical partner in the healthcare supply chain, offering end-to-end solutions from prototyping to high-volume commercial production. By maintaining a diverse portfolio of single-use instruments and implantable hardware, the organization ensures the structural reliability of advanced therapeutic procedures. The entity prioritizes manufacturing excellence and technical agility to facilitate the rapid scaling of medical innovations in a highly regulated landscape.

Ent. Value

$300–700M

Equity Value

[members only]

Multiples

EV / Revenue

2x–6x

EV / EBITDA

15x–25x

EV / EBIT

[members only]

Historical Financials (USD)

Year
Rev
EBITDA
EBIT
2017
$100–200M
$10–30M
[members only]
2016
$100–200M
$10–30M
[members only]

Other operations with PARAGON MEDICAL

Other operations with PARAGON MEDICAL

List of similar M&A transactions (Date, Acquirer, Target, Country, Sub-sector)
DateAcquirerTargetCountrySector
11/2023AMETEKPARAGON MEDICALUNITED STATESMedical Devices
04/2020AMERICAN SECURITIESPARAGON MEDICALUNITED STATESMedical Devices

REFERENCES

Valuation range: EV $300–700M

Revenue range: $100–200M

EBITDA range: $10–30M

EV/Revenue range: 2x - 6x

EV/EBITDA range: 15x - 25x

Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of PARAGON MEDICAL by NN are reserved for mynth community members. Register for free to unlock full data.

Authors: This transaction was contributed by a verified mynth contributor and cross-checked against available transaction documents and official company communications.

Press release: view release

Target: paragon medical

Acquirer: nn